Physician

Mohammad Otahbachi, M.D.

According to 2025 Medicare claims, Mohammad Otahbachi, M.D. (NPI: 1184818353) practices cardiology in the Lubbock, TX market, with the plurality of this provider's patient population coming from Lubbock, TX. This provider's primary affiliated billing organization is COVENANT MEDICAL GROUP (NPI: 1376598904; TIN: 752745546) and primary practice location at 79410-1220. Otahbachi is affiliated with the Covenant ACO, Inc. (ACO ID: A2021), Caravan Health ACO 43 LLC (ACO ID: A4974), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Otahbachi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,469 traditional Medicare patients, billed 6,157 HCPCS/CPT codes, and received $433,985 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 11,473 prescription claims across 1,283 beneficiaries totaling $1,876,300 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 11 claims. Open Payments data shows 67 records totaling $1,662. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $302,061 to $433,985. Similarly, Part D prescription costs have moved sharply higher in recent years, from $68,249 to $1,876,300. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	845	4,672	$302,061
2016	1,015	5,007	$311,836
2017	1,208	6,378	$414,839
2018	1,104	7,225	$514,892
2019	1,270	7,652	$523,774
2020	1,513	7,368	$483,796
2021	1,485	8,223	$523,068
2022	1,511	6,940	$513,213
2023	1,560	7,374	$559,713
2024	1,469	6,157	$433,985

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	291	2,738	$68,249
2016	384	3,816	$119,711
2017	479	4,601	$177,938
2018	574	5,513	$272,500
2019	693	6,722	$460,900
2020	1,111	9,267	$764,079
2021	1,320	14,081	$1,481,141
2022	1,294	12,478	$1,758,447
2023	1,290	12,047	$2,056,088
2024	1,283	11,473	$1,876,300

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$25,646
2017	N/R	12	$25,276
2018	N/R	15	$27,125
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	11	$22,819
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	191	192	$299
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	501	522	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	994	1,534	$85
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	177	177	$47
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,076	1,536	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	933	46,872	$890,998
Entresto	Sacubitril/Valsartan	236	13,512	$292,565
Xarelto	Rivaroxaban	136	6,454	$118,609
Repatha Sureclick	Evolocumab	122	3,946	$74,231
Brilinta	Ticagrelor	83	4,305	$61,595

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	67	$1,662	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohammad Otahbachi, M.D.?

Tedicare shows public-source Medicare data for Mohammad Otahbachi, M.D. (NPI 1184818353), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohammad Otahbachi, M.D. have ACO affiliation data?

Mohammad Otahbachi, M.D. is shown with ACO affiliation data for Covenant ACO, Inc. (MSSP, ACO ID A2021), Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Mohammad Otahbachi, M.D.?

Mohammad Otahbachi, M.D. is linked to COVENANT MEDICAL GROUP (billing NPI 1376598904) in the available physician profile data.

Does Mohammad Otahbachi, M.D. have Open Payments data?

Mohammad Otahbachi, M.D. has 67 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.